The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMyhlth Chck Regulatory News (MHC)

Share Price Information for Myhlth Chck (MHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.75
Bid: 9.50
Ask: 10.00
Change: -0.25 (-2.50%)
Spread: 0.50 (5.263%)
Open: 10.00
High: 10.00
Low: 9.75
Prev. Close: 10.00
MHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

24 Nov 2022 10:37

RNS Number : 5054H
MyHealthChecked PLC
24 November 2022
 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

 

MyHealthChecked PLC

("MyHealthChecked" or the "Company")

 

Director/PDMR Dealing

 

MyHealthChecked plc (AIM: MHC), the consumer home-testing healthcare company, announces that Nicholas Edwards, Chief Financial Officer of the Company, purchased 125,000 Ordinary Shares of 0.1p each in the Company ("Ordinary Shares") at a price of 1.849p per Ordinary share (the "Purchase"). Following the Purchase, Nicholas Edwards has a beneficial interest of 125,000 Ordinary Shares, representing 0.016 per cent. of the total issued share capital.

 

In addition, Lesley Innes, Non-Executive Director, purchased 250,000 Ordinary Shares of 0.1p each at a price of 1.835p per Ordinary Share. Following the Purchase, Lesley Innes has a beneficial interest of 250,000 Ordinary Shares, representing 0.032 per cent. of the total issued share capital.

 

 

For further information contact:

 

MyHealthChecked plc

www.myhealthchecked.com

Penny McCormick, Chief Executive Officer

via Walbrook PR

Nicholas Edwards, Chief Financial Officer

SPARK Advisory Partners Limited (NOMAD)

Tel: +44 (0)20 3368 3550

Neil Baldwin

Oberon Capital Ltd (Broker)

Tel: +44 (0)20 3179 5344

Mike Seabrook

mikeseabrook@oberoninvestments.com

Walbrook PR Ltd (Media & IR)

Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com

Anna Dunphy

Mob: +44(0)7876 741 001

 

 

About MyHealthChecked PLC (www.myhealthcheckedplc.com)

 

 

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests, supported by a user-friendly digital interface..

 

MyHealthChecked is the umbrella brand of a range of at-home wellness tests that are available online, and will be viable for over-the-counter purchase.

 

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 

1

 

Details of the person discharging managerial responsibilities/person closely associated

 

a)

 

Name

 

 

Nicholas Edwards

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Financial Officer

b)

 

Initial notification/amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

MyHealthChecked PLC

 

b)

 

LEI

 

 

213800RBHY6LZDG13168

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 0.1p each

Identification code

GB00BYZ2R301

b)

 

Nature of the transaction

 

 

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

1.849p

125,000

d)

 

Aggregated information

- Aggregated volume

N/A - Single transaction

- Price

e)

 

Date of the transaction

 

 

24 November 2022

f)

 

Place of the transaction

 

 

AIM, London Stock Exchange (XLON)

 

1

 

Details of the person discharging managerial responsibilities/person closely associated

 

a)

 

Name

 

 

Lesley Innes

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-Executive Director

b)

 

Initial notification/amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

MyHealthChecked PLC

 

b)

 

LEI

 

 

213800RBHY6LZDG13168

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 0.1p each

Identification code

GB00BYZ2R301

b)

 

Nature of the transaction

 

 

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

1.835p

250,000

d)

 

Aggregated information

- Aggregated volume

N/A - Single transaction

- Price

e)

 

Date of the transaction

 

 

24 November 2022

f)

 

Place of the transaction

 

 

AIM, London Stock Exchange (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBZLFLLFLXFBE
Date   Source Headline
7th Jul 20219:06 amRNSSecond Price Monitoring Extn
7th Jul 20219:01 amRNSPrice Monitoring Extension
7th Jul 20217:00 amRNSTrading update
2nd Jul 202111:08 amRNSSecond Price Monitoring Extn
2nd Jul 202111:02 amRNSPrice Monitoring Extension
2nd Jul 20219:03 amRNSPrice Monitoring Extension
29th Jun 202111:15 amRNSResult of AGM
28th Jun 20217:00 amRNSAcquisition of genetic testing & nutrition company
25th Jun 20214:43 pmRNSSecond Price Monitoring Extn
25th Jun 20214:36 pmRNSPrice Monitoring Extension
25th Jun 20212:06 pmRNSSecond Price Monitoring Extn
25th Jun 20212:00 pmRNSPrice Monitoring Extension
4th Jun 20217:02 amRNSNotice of Annual General Meeting
4th Jun 20217:01 amRNSBoard Changes
4th Jun 20217:00 amRNSPreliminary Results
1st Jun 20214:42 pmRNSSecond Price Monitoring Extn
1st Jun 20214:37 pmRNSPrice Monitoring Extension
1st Jun 20212:07 pmRNSSecond Price Monitoring Extn
1st Jun 20212:01 pmRNSPrice Monitoring Extension
1st Jun 202111:06 amRNSSecond Price Monitoring Extn
1st Jun 202111:02 amRNSPrice Monitoring Extension
20th May 20212:23 pmRNSRelated Party Transaction
17th May 20217:00 amRNSAdditional Boots agreement for D2/D8 testing
29th Apr 20212:00 pmRNSPrice Monitoring Extension
6th Apr 20214:41 pmRNSSecond Price Monitoring Extn
6th Apr 20214:37 pmRNSPrice Monitoring Extension
6th Apr 20212:30 pmRNSDirectorate Change
6th Apr 20212:06 pmRNSSecond Price Monitoring Extn
6th Apr 20212:01 pmRNSPrice Monitoring Extension
6th Apr 20211:54 pmRNSAgreement with Boots for COVID-19 sample kits
29th Mar 20214:41 pmRNSSecond Price Monitoring Extn
29th Mar 20214:37 pmRNSPrice Monitoring Extension
29th Mar 20214:00 pmRNSFurther COVID-19 Government testing approvals
9th Mar 202112:15 pmRNSTR-1: Notification of major holdings
9th Mar 202111:06 amRNSSecond Price Monitoring Extn
9th Mar 202111:01 amRNSPrice Monitoring Extension
2nd Mar 20219:06 amRNSSecond Price Monitoring Extn
2nd Mar 20219:02 amRNSPrice Monitoring Extension
1st Mar 202111:06 amRNSSecond Price Monitoring Extn
1st Mar 202111:00 amRNSPrice Monitoring Extension
1st Mar 202110:00 amRNSComment on Share Price Movement
24th Feb 20212:27 pmRNSTR-1: Notification of major holdings
19th Feb 20219:53 amRNSDirector/PDMR Shareholding
18th Feb 20214:41 pmRNSSecond Price Monitoring Extn
18th Feb 20214:37 pmRNSPrice Monitoring Extension
18th Feb 202111:25 amRNSResult of General Meeting
18th Feb 20219:05 amRNSSecond Price Monitoring Extn
18th Feb 20219:00 amRNSPrice Monitoring Extension
17th Feb 20214:40 pmRNSSecond Price Monitoring Extn
17th Feb 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.